Introduction
Although the literature contains many reviews of chronic active hepatitis in adults, Mistilis and Blackburn (1970) , Read, Sherlock and Harrison (1963) , Soloway et al. (1972) , Baggenstoss et al. (1972) there are few reports which deal exclusively with this entity in the paediatric age group and are based on a significant number of patients, Page, Good and Pollora (1969) , Dubois, Silverman and Slovis (1972) .
This report concerns our experience with thirtyeight children with chronic active hepatitis, the majority having presented in the last 5-7 years. Follow-up of these patients has provided an opportunity to determine the effect of corticosteroid and azathioprine therapy on the course of children with chronic active hepatitis. In addition, observation of these patients has revealed certain clinical and biochemical differences between paediatric and adult patients with this syndrome.
Materials and methods Clinical
The patient group was composed primarily of referral patients drawn from a large geographic area of urban and rural composition. The diagnosis of chronic active hepatitis was made on accepted clinical, biochemical, immunologic and histologic criteria, Soloway et al. (1972) , Baggenstoss et al. (1972) . Thirty-six of the patients represented sporadic cases since neither contact with known jaundice subjects nor secondary spread could be established. In one patient there was definite contact with hepatitis A, while another developed chronic active hepatitis 5 years after her sibling.
The subsequently confirmed histologically at autopsy in two of these subjects and in the third, 2-3 months after the institution of therapy at which time the bleeding diathesis had markedly improved. Azathioprine (1 mg/kg/day) was added to the therapeutic regimen in twenty-two patients. However, this therapy was usually withheld until clinical and biochemical improvement appeared. Serial measurements of white blood cells and platelet counts were performed after the introduction of azathioprine. In all but three of the treated patients, attempts were then made to reduce the corticosteroid dosage to low maintenance levels (10 mg or less per day, or 10-20 mg every other day) and were discontinued along with azathioprine in fifteen patients from 6 months to 4 years after initiating therapy.
All fifteen had been in clinical and biochemical remission for periods of 5 months to 3 years. The majority, however, had been in remission from 18 to 24 months before slowly weaning from therapy. A low salt diet and diuretics were occasionally needed for management of ascites. Lasix® 0-5-1 mg/kg given orally in two divided doses proved effective. Rarely was it necessary to add Aldactone-A® (1 5-3.0 mg/kg/day in four divided doses) to the therapeutic regimen. Azulfidine® (2-4 g/day) was used with excellent symptomatic response in three patients who developed acute colitis.
Orthotopic liver transplantation, Starzl (1969) Five of these thirteen patients had persistent marked hyperbilirubinaemia (serum total bilirubin greater than 20 mg/100 ml) and prothrombin time below 30 % of normal, despite corticosteroid therapy. This finding was associated with a poor prognosis; three patients died, another lapsed into hepatic coma but survived while the fifth underwent orthotopic liver transplantation 1 year after the apparent onset of disease.
One other patient had marked hyperbilirubinaemia and prothrombin time below 30% of normal. This subject, however, improved markedly with corticosteroid therapy and presently is in clinical and biochemical remission 12 months after discontinuing therapy.
Repeat liver biopsies have been performed in six patients (five open and one autopsy) with persistent or~recurrent clinical and biochemical abnormalities.
All revealed evidence of cirrhosis with varying degrees of activity. Closed liver biopsies were performed on two patients in clinical and biochemical remission but still on therapy. In both cases inadequate tissue was obtained.
There have been eight deaths attributable to either the primary disease or the combination of disease and drug therapy. One patient died of hepatic insufficiency 1 week after prednisone was instituted. Another died of hepatic insufficiency within 6 months of the onset of disease, despite treatment with corticosteroids and azathioprine for 4 months. In another gastrointestinal bleeding, hepatic coma and death occurred 4-5 years after the institution of corticosteroid therapy. Two other patients died of sepsis while on both prednisone and azathioprine, one having pseudomonas sepsis in association with extensive subacute hepatitis with multilobular necrosis (submassive hepatic necrosis) the other shigellosis. Three other patients have subsequently died following orthotopic liver transplantation (Starzl, personal communication) .
Discussion
There are many similarities between paediatric and adult patients with chronic active hepatitis, however, certain differences in clinical and biochemical patterns and therapeutic responses are worth noting.
In adults the onset is usually insidious in nature, often with extra hepatic manifestations predominating. In one large series (Mistilis and Blackburn 1970) , only about one-third of patients had an abrupt onset with clinical and laboratory features indistinguishable from acture viral hepatitis. Conversely, the onset was acute in 63 % of our patients. Page et al. (1969) Conversely, although the onset was acute in the majority of our patients, HB Ag was negative in all twenty-eight patients tested.
In adult patients SGOT rarely exceeds 500 i.u./l and is a useful point when differentiating acute viral hepatitis from chronic active hepatitis, Mistilis and Blackburn (1970) . In the present series the mean SGOT was significantly greater than this level. The reason for this difference is not known, however, this may be related to the frequent acute onset noted in younger patients. Although in the present series there was no correlation between the degree of SGOT elevation at the time of diagnosis and type of onset. Unfortunately, transaminase levels were not reported in the only other large series of children with chronic active hepatitis, Page et al. (1969) .
Hypergammaglobulinaemia was present in every case, but not to the same degree observed in the children reported by Page et al. (1969) . In contrast to the lack of diagnostic value of hypergammaglobulinaemia in adults, Mistilis and Blackburn (1970) , it proved extremely useful in our experience in distinguishing chronic active hepatitis from either recurrent or persistent viral hepatitis.
The importance of excluding Wilson's disease in any young patient with hepatic dysfunction has been frequently stressed, Slovis et al. (1971) , however, with appropriate studies Wilson's disease can be readily distinguished from chronic active hepatitis, Sternlieb and Scheinberg (1972) . Similarly, druginduced hepatitis should always be considered, Goldstein, Lam and Mistilis (1973) . In retrospect, none of our patients had taken oxyphenisatin or alpha methyl-dopa.
It is now well established that corticosteroid therapy significantly reduces the mortality in the early active phase of chronic active hepatitis, Blackburn (1970), Soloway et al. (1972) , Cook et al. (1971) , Murray-Lyon, Stern and Williams (1973) . The majority of our patients had a prompt clinical remission with improved well-being following the institution of corticosteroid therapy. All three of our patients who died early in the course of the disease despite corticosteroid therapy had submassive hepatic necrosis.
The side effects of prolonged corticosteroid therapy (cosmetic, growth retardation, osteoporosis and increased protein catabolism) are usually more serious in children than adults. These side effects may occur even in the smaller corticosteroid dosage employed by Cook et al. (1971) .
Combined azathioprine and prednisone is no more effective than prednisone alone in improving the various indicators of disease activity, Soloway et al. (1972) . However, the introduction of azathioprine in the long-term management of chronic active hepatitis in children has been extremely beneficial in reducing untoward side-effects of corticosteroid therapy. Most of our patients could be maintained in clinical and biochemical remission while taking small doses of prednisone in combination with azathioprine.
Institution of azathioprine may lead to haematologic or hepatic complications, however, this was not a problem in our experience. Similarly, the risk of infection is enhanced with azathioprine therapy and in the present study two patients died with sepsis.
The effect of therapy on the biochemical abnormalities and the occurrence of relapse following discontinuation of therapy is variable, Read et 
Dialogue developed between Dr Javitt and Dr Dubois on the importance of the sex of the patient in the response to immuno-suppressants, particularly azathioprine. Dr Javitt took the view that there was no good evidence that males actually benefit from such therapy, for example, in the study from the Mayo clinic , twelve of the thirteen patients who were treated with azathioprine alone were male and therefore one could almost have predicted that the outcome in these patients would not be satisfactory. In a study from the Royal Free (Cook et al., 1971) , female patients predominated in the treated group. Dr Dubois agreed with these observations and said that the majority of their patients were in fact females, but he was not sure what the importance of this was since most of the patients were pre-pubertal. All eight who died were female.
